Startups

InvestMaryland chair takes CEO position with Mass.-based biotech firm

Peter Greenleaf will join biotech firm Histogenics.

Peter Greenleaf flanked by Governor O'Malley and Christian Johansson, former chief of the Department of Business and Economic Development.

Peter Greenleaf, chair of the board overseeing the $84 million InvestMaryland venture fund, is taking a CEO job with Massachusetts-based biotech company Histogenics.
Greenleaf, former president of MedImmune in Gaithersburg, will remain chairman of the InvestMaryland board, a four-year position, at the request of Governor Martin O’Malley.
Read more here.

Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Donate to the Journalism Fund

Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.

Trending

What internet speed do you really need?

How DC protesters are protecting themselves online while calling out the Trump administration

Baltimore-area libraries are a gold mine of resources for entrepreneurs

Developing tech for government agencies? Participant advisory councils can help get it right.

Technically Media